Preimplantation development in rodent and primate establishes the founding cell population of the foetus in the epiblast and segregates two extraembryonic lineages, trophoblast and hypoblast. Most of our current knowledge about these cell-fate decisions is derived from studies in mouse. However, transcriptional profiling of human embryos has suggested substantial differences to the mouse paradigm.
Preimplantation development in rodent and primate establishes the founding cell population of the foetus in the epiblast and segregates two extraembryonic lineages, trophoblast and hypoblast. Most of our current knowledge about these cell-fate decisions is derived from studies in mouse. However, transcriptional profiling of human embryos has suggested substantial differences to the mouse paradigm.
Here, we set out to delineate the primate-specific aspects of preimplantation development. We present a high-quality single-cell RNA-seq dataset from zygote to late blastocyst in marmoset (Callithrix jacchus). In addition, we generated stage-matched samples in mouse (Mus musculus) and re-analysed three human single-cell datasets. Weighted gene network analysis independently identified the establishment of epiblast and hypoblast transcriptional modules. NANOG, SOX2, TDGF1 and TFCP2L1 were highly expressed in the epiblast of all three species. In contrast, KLF17, ARGFX, KHDC3L, LEFTY2 and CTSF represented primate-specific factors of the pluripotency network in vivo. Global features of epiblast and hypoblast segregation included the ERK cascade, apoptosis and extracellular matrix, while we identified elevated levels of BMP and WNT signalling components in primates. Strikingly, the mouse epiblast marker Otx2 is specifically expressed in human and marmoset hypoblast.
Our cross-species analysis approach demarcates conserved and primate-specific features of mammalian preimplantation development and provides a rich resource for comparative embryology. Here, we analyze a role of transmembrane protein 107 (Tmem107) in craniofacial structures development with special focus on palate formation. Tmem107-/-mice exhibited a broad spectrum of craniofacial defects including shorter snout, expansion of the facial midline, extensive exencephaly and microphthalmia or anophthalmia. Tmem107 homozygous null embryos also displayed reduced oral cavity and a smaller, abnormally shaped tongue. External abnormalities were accompanied by defects of skeletal structures with enlargement or duplication of the nasal septum. Extensive cleft lip was in most of cases, oriented to the right side.
Insufficiency in palatal shelf growth resulted in clefting of the secondary palate. When palatal shelves did fuse at the midline, they did not attach to the shortened nasal septum. Palatal defects were caused by increased proliferation, and differences in Shh expression in palatal shelves, while the number of apoptotic cells was comparable to littermate controls. Moreover, the expression of Wnt signalling receptor Fzd6 was found to be downregulated in the palatal shelves. Incisors were missing or reduced while molars exhibited normal morphology indicating region-specific response to Tmem107 deficiency. Thus, Tmem107 seems to be essential for proper head development, and the craniofacial phenotype, including the expansion of the facial midline, corresponds to the disruption in Hedgehog pathway activity. Further analysis of Tmem107's role during embryonic development and the role of cilia in non-canonical WNT signaling in craniofacial development can provide insight into the causations of region-specific response of individual structures. In vitro production of hematopoietic stem cells (HSCs) from pluripotent stem cells remains a challenge. Unlocking the roles of accessory cells at sites of HSC production may help clarify whether these cells or their products constitute a missing element in current protocols. HSCs originate from hemogenic-endothelium that lines the ventral surface of the dorsal aorta in E10.5 embryos. We have identified distinct PDGFRA+/Nestin-GFP+ (N-GFP) and PDGFRA+/ N-GFP-cells populations with colony forming unit-fibroblast (CFU-F) activity in the E11.5 AGM. Whereas PDGFRA+/N-GFP-CFU-Fs in the AGM can be serially passaged and show long-term clonogenicity, PDGFRA+/N-GFP+ CFU-Fs show limited self-renewal. These AGM CFU-Fs showed in vitro differentiation potential into mesodermal and ectodermal derivatives but those of the endoderm. PDGFRA-/N-GFP+/PDGFRB +/CD31+ cells possess haematopoietic CFU-C potential whereas PDGFRA+/N-GFP+/PDGFRB +/CD31-cells lack CFU-C but retain CFU-F potential. Conditional ablation of PDGFRA+/ Nestin+ or PDGFRA+/Nestin-cells in the AGM led to either partial or complete loss of CFU-Fs respectively, with severe loss of endothelial and pericyte-like cells and concomitant loss of blood formation. PDGFRA+ cells progressively acquire Nestin expression as they migrate towards the aortic lumen. Tamoxifen induced lineage tracing in PDGFRACreERT2/R26eYFP mice showed that stromal, subendothelial, endothelial and hematopoietic cells including long term repopulating HSCs (LT-HSCs) in E11.5 AGM are progeny of PDGFRA cells. To trace the origins of these stromal cells, we used Mesp1/ R26eYFP (mesoderm) and Wnt1/R26eYFP (neural crest) reporter mice and observed that MesP1 derived PDGFRA+ cells dominated the sub-endothelial and deeper ventral stroma in the AGM at E11.5 but are replaced by Wnt1 derived cells by E13.5. In vitro reaggregation of E11.5 Mesp1 derived PDGFRA+/PDGFRB-/CD45-/ CD31-/VE-CAD-MSC-LC cells with E13.5 or adult cardiac nonhemogenic endothelial cells (PDGFRA-/PDGFRB-/CD45-/CD31 +/VE-CAD+) resulted in the generation of endothelial cell derived LTAbstracts S55
